lymph node fnab & ancillary testing drs. e. filter, d. morrison & m. weir
TRANSCRIPT
LYMPH NODE FNAB & ANCILLARY TESTING
Drs. E. Filter, D. Morrison & M. Weir
INTRODUCTION
Lymphadenopathy in setting of thyroid nodule or post thyroidectomy
- requires imaging, work-up- sometimes diagnosis - FNAB
LN diagnosis & staging important - changes management
Ancillary testing - useful with FNAB
OBJECTIVES
For Lymph Node FNABs:1. State roles of ancillary testing for
- thyroglobulin, flow cytometry
2. List reasons for non-correlation between
FNAB & thyroglobulin
CASE 1
LPP 51 year old female
Hx pap thyroid ca 1995, surgery, RAI Serum Tg undetectable, Stim Tg <1,
WBS - N Suspicious left neck level 3 lymph
node FNAB & Tg testing on sample
Nuclear atypia
Comparison to benign thyroid epithelium
Pap society atlas
CASE 1
Jan 2014- FNAB: positive for papillary
carcinoma
- Tg on FNAB sample: abnormal
QUESTIONS: why do the Tg at all? why not do just Tg (omit
FNAB)
CASE 1
QUESTIONS: 1. Why do the Tg at all?
- literature to support reflex testing
- cost conscious, limited resources
2. Why not do just Tg alone (omit FNAB)?
- it is only for DTC (foll, pap ca)
- + FNAB has high PPV
LITERATURE
Thyroglobulin Wash Testing in the Surveillance of Patients with Thyroid Carcinoma: Proposal for a Reflex Test
Anastasiya Pigal, Rossitza Draganova- Tacheva, Charalambos C. Solomides, Marluce Bibbo.
Bibbo paper
Retrospective study Determine if Tg sample contributed
to management of cases with + FNAB
30 susp/pos LN or thyroid bed FNABs
Hx of or subsequent histologically proven differentiated thyroid ca (DTC – foll or pap ca)
Lit review (DTC only)
Bibbo paper
Susp/Pos FNAB
Tg > 1 ng/mL
Tg < 1 ng/mL
Tg negative DTC on F/U
30 Bibbo23 LN, 7 bed
22 (73%) 8 (27%) 7
577 Lit review
548 LN, 29 bed
557 (97%)
20 (3%) 14
All treated regardless of Tg outcomes
Bibbo paper
Their data & literature review:
- recommend reflex Tg testing of FNAB
ONLY for neg/indeterminate cytology
- + Tg in setting of susp/pos FNAB
- no change management
PRACTICE REFLECTION
Now:- in Plasmalyt: divide for cyto/Tg- all samples sent are tested
Should we change our practice?- medium to store Tg?- hold Tg until FNAB reported?- who initiates Tg testing?
CASE 2
VB R thyroid nodules
- lower 2.6 cm nodule, microcalcifications
- 2.2 cm R cervical LN > 4 cm Lung nodules FNABs x3 (2 nodules, LN)
Case 2 Thyroid NodulesThyroid Nodules:
● Location: Right Mid Lobe● Approximate Size: 1.6 x 2.2 x 2.4 cm● Location: Right Lower Lobe● Approximate Size: 1.7 x 2.6 cm x ?(went
below clavicle)
● Echogenicity: Both Hypoechoic● Taller than Wide (transverse) Ratio: Yes● Vascularity: Yes● Margins: Indistinct
Case 2 Lymph Node Biopsy
Lymph Node:● Location: Right Cervical Level 4.● Approximate Size: 2.8 x 3.4 x >4cm● Echogenicity: Hypoechoic● Appearance: Round with no fatty hilum● Vascularity: Yes● Margins: Regular
+ CALCITONIN
Pap society atlas
CASE 2
FNAB- medullary carcinoma (thyroid,
LN)
Tg on FNAB sample not elevated
Discrepancy between +FNAB & -Tg- not DTC, so Tg expected to be
neg Note: Tg alone would be false neg
CASE 2
Reasons for negative Tg when +FNAB?
CASE 2 Reasons for negative Tg when
+FNAB- not papillary or follicular
carcinoma- sampling (false neg)
- passes different material- low cellularity/unsatisfactory
- test issue (false neg)- collection tube type- circulating antithyr Ab
Roseneide et al Thyroid 2014Thyroglobulin in the Washout Fluid of Lymph Node Biopsy
Summary 1 (Cases 1&2)
Role of Tg testing:- not for susp/pos LN outcomes- use with FNAB, not alone
Reasons for non-correlation LN FNAB & Tg:
- not DTC- sampling, test issue
CASE 3
OH Left thyroid nodule Left level 4 lymph node FNABs x2
THYROID FNAB
Few groups, focal atypia
crowdingpseudoinclusionsgrooves
CASE 3
Thyroid FNAB- Indeterminate for pap ca (AUS)
LN FNAB- Indeterminate
- low cellularity, few epithelial groups Tg on FNAB elevated
CASE 3
Role of Tg
- best use: indeterminate/neg FNAB
- has high sensitivity in this setting
- will impact management
CASE 3
Reasons for positive Tg when neg/ind FNAB?
CASE 3 Reasons for positive Tg when
neg/ind FNAB- sampling
- go thru thyroid for central LN- cystic LN, low cellularity/unsat- thyroid bed residual thyroid
tissue
- test issues- saline collection – matrix effect- high serum Tg- thyroid palpation effect (Tg
released)
Roseneide 2014
CASE 4
HK
Hx papillary carcinoma 2006 Thyroid nodule in bed query LN FNAB
CASE 4
?LN FNAB- low cell, negative (lymphocytes)- may not be representative
Tg on FNAB not elevated
CASE 4
Is a neg Tg reassuring when FNAB neg?
- maybe- beware sampling:
- FNAB low cellularity or unsat
- Tg sample may not be representative
Tg TESTING ISSUES
Lack consensus, international standards
for performance & interpretation
Measure Tg FNAB same method as sTg
Tg free serum in Tg assay kit preferable to washing in saline
Use 1 mL fluid, plain serum tubes Cut off for measurement -
controversial
Roseneide 2014 Thyroid
PRACTICE REFLECTION
Now:- in Plasmalyt, not
serum tube- variable volumes
Should we change our practice?
- Tg free serum?- serum tubes- 1 mL
Summary 2 (Cases 3&4)
Role of Tg testing:- use for neg/indeterminate FNABs- will impact management- beware of neg Tg when unsat/lo
cell FNAB
Reasons for non-correlation LN FNAB - Tg:
- sampling, test issues
CASE #5:CERVICAL LYMPHADENOPATHY
Case #5 72 year old female Hx non-diagnostic thyroid nodules
No clinical risk factors, stable sizes, no suspicious sonographic features on left, benign biopsy (low cellularity) on right.
Now presenting with left cervical lymphadenopathy
FNA of lymph nodes (levels 4, 5b) obtained
Thyroid Nodules
Lymph Nodes
Smear (Pap stain)
Cibas, E. Cytology, 3rd, Ed. 2009
Air dried smear (DiffQuik stain)
Case #5
Flow cytometry reported 2 monoclonal B-cell populations
The morphologic findings and flow cytometry results are consistent with a B-cell lymphoproliferative disorder
A non-Hodgkin lymphoma (NHL) is favoured
Ancillary Studies in Lymphoma Dx
Immunocytochemistry panels Molecular studies Flow cytometry
Flow Cytometry
Flow Cytometer
Cibas, E. Cytology, 3rd, Ed. 2009
Flow Cytometry
Markedly improves the diagnostic sensitivity in cases of suspected NHLs
:. recommended ancillary study if clinical DDx includes lymphoma BUT: less useful in cases of Hodgkin
lymphoma and plasma cell dyscrasias
Flow Cytometry
Requires submission of your sample in flow medium (RPMI) Refrigerated Can use Plasmalyte if
RPMI not immediately available
Formalin and alcohol-based solutions (e.g. Cytolyt) not optimal for flow interpretation
www.lifetechnologies.com
Role of FNA in Lymphoma Dx
DISADVANTAGES
Samples may be non-diagnostic Necrosis Fibrosis Poor technique
Samples may not be representative Benign and malignant lymphoid cells can co-exist in same
lymph node Reactive lymphadenopathies and malignancies can
mimic lymphomas Grading of lymphomas poorly reproducible in
cytologyDeMay, R. The Art & Science of Cytopathology,
2nd Ed., 2012
Role of FNA in Lymphoma Dx
ADVANTAGES
Does not interfere with subsequent histologic interpretation
Can help select best node for excision Ideal in certain situations:
Deep or surgically inaccessible nodes Patients of high surgical risk Rapidly progressive and/or extensive disease
Can document transformation to a higher-grade lymphoma (e.g. Richter syndrome)
DeMay, R. The Art & Science of Cytopathology, 2nd Ed., 2012
In Summary…
The diagnosis of lymphoma requires a clinicopathologic approach AND use of ancillary studies
Although there are known pitfalls, FNA cytology can be very useful for proving or excluding a lymphoma
Flow cytometry is key to diagnosis
TAKE HOME MESSAGES
Role of ancillary testing for LN FNABs
- Tg: ind/neg FNABs - flow cytometry: confirm reactive/lymphoma
Reasons for non-correlation FNAB & Tg:
- sampling- nature of lesion- test issues